+22
Abbott
For patients with implanted cardiac or neuromodulation devices, medical professionals performing structural heart interventions, and health-conscious consumers.
Known forAbbott Benefits - Asia
For patients with implanted cardiac or neuromodulation devices, medical professionals performing structural heart interventions, and health-conscious consumers.
Providing integrated digital interfaces for medical devices and metabolic health tracking to improve patient outcomes and clinical data access.
Target audience
Rivals analysis in progress
Portfolio
Free 25Last updated
Abbott Benefits - Asia
Primary focus
Medical device companion apps and metabolic health tracking
Scale
studio
Target audience
Patients with implanted cardiac or neuromodulation devices, medical professionals performing structural heart interventions, and health-conscious consumers.
The publisher released 7 updates in the last 6 months, with a major release occurring just 2 days ago, indicating high current development focus on their active titles.
25 apps analysed
Analysis in progress
Analysis in progress
Single-market publisher — every app ships only to United States.
Based on 1 of 25 apps with localized market data — more coverage rolling in as scans complete · last scanned .
User-sentiment analysis coming soon.
Rival analysis coming soon.
Strategic outlook coming soon.
What fed this analysis
